I just cant see how our direct marketing to alternate pathology...

I just cant see how our direct marketing to alternate pathology labs and DTC/DTP is a viable strategy, especially at any kind of scale. There is a reason smaller biotech firms market their products through major providers with extensive built-up networks.

This is raising all kinds of red flags to me, especially given the ridiculously limited amount of explanation as to why nobody can seemingly market our primary product - and thus why we need to fiddle about trying to do it ourselves.

I don't think this is going to end well, but I'll need some more information first before either pressing the eject button or staying in the game. Hopefully some of that information is provided soon